Elite Pharmaceuticals Inc (OTCBB - OTCQB:ELTP)
| 0.0705 Data as of May 17 |  0.00 / 0.00%Today’s Change | 0.05 Today|||52-Week Range 0.17 | -11.76% Year-to-Date |
Latest ELTP News | Press Releases
No recent news for Elite Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.07 |
| Today’s open | 0.07 |
| Day’s range | 0.07 - 0.07 |
| Volume | 1,159,729 |
| Average volume (3 months) | 1,019,985 |
| Market cap | $25.1M |
| Dividend yield | -- |
Data as of 3:59pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +57.14% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -43.18% |
| P/E ratio | NM |
| Price/Sales | 9.52 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRPHProPhase Labs Inc | +0.01 | +0.86% |
| PTNPalatin Technologies... | +0.02 | +3.23% |
| ASTMAastrom Biosciences ... | -0.02 | -3.39% |
| CRMECardiome Pharma Corp | +0.03 | +1.42% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $2.4M |
| Annual profit (last year) | -$15.1M |
| Net profit margin | -621.19% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
Chairman & Chief Executive Officer Jerry I. Treppel, CFA, MBA |
President, Chief Operating Officer & Director Christopher C. Dick, MBA |
Corporate headquarters Northvale, New Jersey |
Forecasts
